Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

The International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment.

Schulze TG, Alda M, Adli M, Akula N, Ardau R, Bui ET, Chillotti C, Cichon S, Czerski P, Del Zompo M, Detera-Wadleigh SD, Grof P, Gruber O, Hashimoto R, Hauser J, Hoban R, Iwata N, Kassem L, Kato T, Kittel-Schneider S, Kliwicki S, Kelsoe JR, Kusumi I, Laje G, Leckband SG, Manchia M, Macqueen G, Masui T, Ozaki N, Perlis RH, Pfennig A, Piccardi P, Richardson S, Rouleau G, Reif A, Rybakowski JK, Sasse J, Schumacher J, Severino G, Smoller JW, Squassina A, Turecki G, Young LT, Yoshikawa T, Bauer M, McMahon FJ.

Neuropsychobiology. 2010;62(1):72-8. doi: 10.1159/000314708. Epub 2010 May 8.

2.

Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge.

Rybakowski JK.

CNS Drugs. 2013 Mar;27(3):165-73. doi: 10.1007/s40263-013-0040-7. Review.

3.

The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample.

Oedegaard KJ, Alda M, Anand A, Andreassen OA, Balaraman Y, Berrettini WH, Bhattacharjee A, Brennand KJ, Burdick KE, Calabrese JR, Calkin CV, Claasen A, Coryell WH, Craig D, DeModena A, Frye M, Gage FH, Gao K, Garnham J, Gershon E, Jakobsen P, Leckband SG, McCarthy MJ, McInnis MG, Maihofer AX, Mertens J, Morken G, Nievergelt CM, Nurnberger J, Pham S, Schoeyen H, Shekhtman T, Shilling PD, Szelinger S, Tarwater B, Yao J, Zandi PP, Kelsoe JR.

BMC Psychiatry. 2016 May 5;16:129. doi: 10.1186/s12888-016-0732-x.

4.

Lithium: clinical considerations in internal medicine.

Freeman MP, Freeman SA.

Am J Med. 2006 Jun;119(6):478-81. Review.

PMID:
16750958
5.

Response to lithium in bipolar disorder: clinical and genetic findings.

Rybakowski JK.

ACS Chem Neurosci. 2014 Jun 18;5(6):413-21. doi: 10.1021/cn5000277. Epub 2014 Mar 25. Review.

6.

[Predictors of prophylactic response to lithium].

Rohayem J, Baylé JF, Richa S.

Encephale. 2008 Sep;34(4):394-9. doi: 10.1016/j.encep.2007.05.002. Epub 2007 Nov 26. Review. French.

PMID:
18922242
7.

Arguments for the specificity of the antisuicidal effect of lithium.

Müller-Oerlinghausen B.

Eur Arch Psychiatry Clin Neurosci. 2001;251 Suppl 2:II72-5. Review.

PMID:
11824842
8.

Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics.

Alda M.

Mol Psychiatry. 2015 Jun;20(6):661-70. doi: 10.1038/mp.2015.4. Epub 2015 Feb 17. Review.

9.

Long-term responsiveness to lithium as a pharmacogenetic outcome variable: treatment and etiologic implications.

Mamdani F, Jaitovich Groisman I, Alda M, Turecki G.

Curr Psychiatry Rep. 2003 Dec;5(6):484-92. Review.

PMID:
14609504
10.

Lithium in bipolar and other affective disorders: prescribing practice in the UK.

Paton C, Barnes TR, Shingleton-Smith A, McAllister-Williams RH, Kirkbride J, Jones PB, McIntyre S; POMH-UK project team.

J Psychopharmacol. 2010 Dec;24(12):1739-46. doi: 10.1177/0269881110367728. Epub 2010 May 20.

PMID:
20488832
11.

An open longitudinal study of patients with bipolar rapid cycling treated with lithium or lamotrigine for mood stabilization.

Walden J, Schaerer L, Schloesser S, Grunze H.

Bipolar Disord. 2000 Dec;2(4):336-9.

PMID:
11252647
12.

Pharmacogenetics of lithium long-term treatment: focus on initiation and adaptation mechanisms.

Serretti A, Drago A.

Neuropsychobiology. 2010;62(1):61-71. doi: 10.1159/000314311. Epub 2010 May 7. Review.

PMID:
20453536
13.

Lithium response viewed as a biomarker to predict developmental psychopathology in offspring with bipolar disorder: a commentary.

Pavuluri MN, Lee MS, Pandey G.

Bipolar Disord. 2015 Mar;17(2):224-32. doi: 10.1111/bdi.12280. Epub 2014 Dec 19. No abstract available.

PMID:
25523965
14.

Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study.

Hou L, Heilbronner U, Degenhardt F, Adli M, Akiyama K, Akula N, Ardau R, Arias B, Backlund L, Banzato CEM, Benabarre A, Bengesser S, Bhattacharjee AK, Biernacka JM, Birner A, Brichant-Petitjean C, Bui ET, Cervantes P, Chen GB, Chen HC, Chillotti C, Cichon S, Clark SR, Colom F, Cousins DA, Cruceanu C, Czerski PM, Dantas CR, Dayer A, Étain B, Falkai P, Forstner AJ, Frisén L, Fullerton JM, Gard S, Garnham JS, Goes FS, Grof P, Gruber O, Hashimoto R, Hauser J, Herms S, Hoffmann P, Hofmann A, Jamain S, Jiménez E, Kahn JP, Kassem L, Kittel-Schneider S, Kliwicki S, König B, Kusumi I, Lackner N, Laje G, Landén M, Lavebratt C, Leboyer M, Leckband SG, Jaramillo CAL, MacQueen G, Manchia M, Martinsson L, Mattheisen M, McCarthy MJ, McElroy SL, Mitjans M, Mondimore FM, Monteleone P, Nievergelt CM, Nöthen MM, Ösby U, Ozaki N, Perlis RH, Pfennig A, Reich-Erkelenz D, Rouleau GA, Schofield PR, Schubert KO, Schweizer BW, Seemüller F, Severino G, Shekhtman T, Shilling PD, Shimoda K, Simhandl C, Slaney CM, Smoller JW, Squassina A, Stamm T, Stopkova P, Tighe SK, Tortorella A, Turecki G, Volkert J, Witt S, Wright A, Young LT, Zandi PP, Potash JB, DePaulo JR, Bauer M, Reininghaus EZ, Novák T, Aubry JM, Maj M, Baune BT, Mitchell PB, Vieta E, Frye MA, Rybakowski JK, Kuo PH, Kato T, Grigoroiu-Serbanescu M, Reif A, Del Zompo M, Bellivier F, Schalling M, Wray NR, Kelsoe JR, Alda M, Rietschel M, McMahon FJ, Schulze TG.

Lancet. 2016 Mar 12;387(10023):1085-1093. doi: 10.1016/S0140-6736(16)00143-4. Epub 2016 Jan 22.

15.

Neuroprotective effect of lithium on hippocampal volumes in bipolar disorder independent of long-term treatment response.

Hajek T, Bauer M, Simhandl C, Rybakowski J, O'Donovan C, Pfennig A, König B, Suwalska A, Yucel K, Uher R, Young LT, MacQueen G, Alda M.

Psychol Med. 2014 Feb;44(3):507-17. doi: 10.1017/S0033291713001165. Epub 2013 May 31.

PMID:
23721695
16.

Lithium: a review of pharmacology, clinical uses, and toxicity.

Oruch R, Elderbi MA, Khattab HA, Pryme IF, Lund A.

Eur J Pharmacol. 2014 Oct 5;740:464-73. doi: 10.1016/j.ejphar.2014.06.042. Epub 2014 Jun 30. Review.

PMID:
24991789
17.

Lithium specificity in bipolar illness: a classic agent for the classic disorder.

Gershon S, Chengappa KN, Malhi GS.

Bipolar Disord. 2009 Jun;11 Suppl 2:34-44. doi: 10.1111/j.1399-5618.2009.00709.x. Review.

PMID:
19538684
18.

Long-term lithium treatment in the prevention of suicidal behavior in bipolar disorder patients.

Tondo L, Baldessarini RJ.

Epidemiol Psichiatr Soc. 2009 Jul-Sep;18(3):179-83. Review.

PMID:
20034193
19.

[Mood stabilizers--past, present and future].

Sümegi A.

Neuropsychopharmacol Hung. 2008 Mar;10(1):31-42. Review. Hungarian.

20.

The science and practice of lithium therapy.

Malhi GS, Tanious M, Das P, Berk M.

Aust N Z J Psychiatry. 2012 Mar;46(3):192-211. doi: 10.1177/0004867412437346. Review.

PMID:
22391277

Supplemental Content

Support Center